Market Research Logo

Global Tardive Dyskinesia Treatment Market 2019-2023

Global Tardive Dyskinesia Treatment Market 2019-2023

About Tardive Dyskinesia

Tardive dyskinesia is the involuntary movement of face and body as a side effect of using antipsychotic drugs for the treatment of mental disorders such as schizophrenia, bipolar disorder, and other brain conditions.

Technavio’s analysts forecast the Global Tardive Dyskinesia Treatment Market to grow at a CAGR of 4.44% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the tardive dyskinesia treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of tardive dyskinesia across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, tardive dyskinesia treatment market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • F. Hoffmann-La Roche
  • Merck
  • Neurocrine Biosciences
  • Novartis
  • Teva Pharmaceutical
Market driver
  • Increasing use of antipsychotic drugs across the globe
  • For a full, detailed list, view our report
  • Market challenge
    • Lack of awareness
    • For a full, detailed list, view our report
    Market trend
    • Increasing R&D on VMAT2 inhibitors
    • For a full, detailed list, view our report
    Key questions answered in this report
    • What will the market size be in 2023 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?


    • Executive summary
    • Scope of the report
    • Market landscape
      • Market ecosystem
        • Table Global CNS therapeutics market
        • Table Segments of global CNS therapeutics market
      • Market segmentation analysis
        • Table Market segments
    • Market sizing
      • Market definition
        • Table Market definition - Inclusions and exclusions checklist
      • Market sizing 2018
        • Table Market size 2018
      • Market size and forecast 2018-2023
        • Table Global market: Size and forecast 2018-2023 ($ millions)
        • Table Global market: Year-over-year growth 2019-2023 (%)
    • Five forces analysis
      • Table Five forces analysis 2018
      • Table Five forces analysis 2023
      • Bargaining power of buyers
        • Table Bargaining power of buyers
      • Bargaining power of suppliers
        • Table Bargaining power of suppliers
      • Threat of new entrants
        • Table Threat of new entrants
      • Threat of substitutes
        • Table Threat of substitutes
      • Threat of rivalry
        • Table Threat of rivalry
      • Market condition
        • Table Market condition - Five forces 2018
    • Market segmentation by product
      • Table Product - Market share 2018-2023 (%)
      • Comparison by product
        • Table Comparison by product
      • AUSTEDO and INGREZZA - Market size and forecast 2018- 2023
        • Table AUSTEDO and INGREZZA - Market size and forecast 2018-2023 ($ millions)
        • Table AUSTEDO and INGREZZA - Year-over-year growth 2019-2023 (%)
      • Others - Market size and forecast 2018-2023
        • Table Others - Market size and forecast 2018-2023 ($ millions)
        • Table Others - Year-over-year growth 2019-2023 (%)
      • Market opportunity by product
        • Table Market opportunity by product
    • Customer landscape
      • Table Customer landscape
    • Geographic landscape
      • Geographic segmentation
        • Table Market share by geography 2018-2023 (%)
      • Geographic comparison
        • Table Geographic comparison
      • Americas - Market size and forecast 2018-2023
        • Table Americas - Market size and forecast 2018-2023 ($ millions)
        • Table Americas - Year-over-year growth 2019-2023 (%)
        • Table Top 3 countries in Americas
      • EMEA - Market size and forecast 2018-2023
        • Table EMEA - Market size and forecast 2018-2023 ($ millions)
        • Table EMEA - Year-over-year growth 2019-2023 (%)
        • Table Top 3 countries in EMEA
      • APAC - Market size and forecast 2018-2023
        • Table APAC - Market size and forecast 2018-2023 ($ millions)
        • Table APAC - Year-over-year growth 2019-2023 (%)
        • Table Top 3 countries in APAC
      • Key leading countries
        • Table Key leading countries
      • Market opportunity
        • Table Market opportunity
    • Decision framework
    • Drivers and challenges
      • Market drivers
        • Table Molecules in late-stage development
        • Table Recent approvals by US FDA
      • Market challenges
        • Table Impact of drivers and challenges
    • Market trends
    • Vendor landscape
      • Overview
        • Table Vendor landscape
      • Landscape disruption
        • Table Landscape disruption
      • Competitive scenario
    • Vendor analysis
      • Vendors covered
        • Table Vendors covered
      • Vendor classification
        • Table Vendor classification
      • Market positioning of vendors
        • Table Market positioning of vendors
      • F. Hoffmann-La Roche
        • Table F. Hoffmann-La Roche - Vendor overview
        • Table F. Hoffmann-La Roche - Business segments
        • Table F. Hoffmann-La Roche - Organizational developments
        • Table F. Hoffmnn-La Roche - Segment focus
        • Table F. Hoffmann-La Roche - Geographic focus
        • Table F. Hoffmann-La Roche - Key offerings
        • Table F. Hoffmann-La Roche - Key customers
      • Merck
        • Table Merck - Vendor overview
        • Table Merck - Business segments
        • Table Merck - Organizational developments
        • Table Merck - Segment focus
        • Table Merck - Geographic focus
        • Table Merck - Key offerings
        • Table Merck - Key customers
      • Neurocrine Biosciences
        • Table Neurocrine Biosciences - Vendor overview
        • Table Neurocrine Biosciences - Organizational developments
        • Table Neurocrine Biosciences - Key offerings
        • Table Neurocrine Biosciences - Key customers
      • Novartis
        • Table Novartis - Vendor overview
        • Table Novartis - Business segments
        • Table Novartis - Organizational developments
        • Table Novartis - Segment focus
        • Table Novartis - Geographic focus
        • Table Novartis - Key offerings
        • Table Novartis - Key customers
      • Teva Pharmaceutical
        • Table Teva Pharmaceutical - Vendor overview
        • Table Teva Pharmaceutical - Business segments
        • Table Teva Pharmaceutical - Organizational developments
        • Table Teva Pharmaceutical - Segment focus
        • Table Teva Pharmaceutical - Geographic focus
        • Table Teva Pharmaceutical - Key offerings
        • Table Teva Pharmaceutical - Key customers
    • Appendix
      • Research methodology
        • Table Validation techniques employed for market sizing
      • List of abbreviations
        • Table List of abbreviations
    • Explore Technavio

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report